Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

[1]  M. Ross,et al.  Catabolism of 4-hydroxy-2-trans-nonenal by THP1 monocytes/macrophages and inactivation of carboxylesterases by this lipid electrophile. , 2011, Chemico-biological interactions.

[2]  M. Ross,et al.  Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  B. Davies,et al.  Surge in expression of carboxylesterase 1 during the post-neonatal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir. , 2011, The Journal of infectious diseases.

[4]  P. Potter,et al.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. , 2010, Chemical research in toxicology.

[5]  L. Tsurkan,et al.  Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin , 2010, British journal of pharmacology.

[6]  J. Cashman,et al.  Human Carboxylesterase 1 Stereoselectively Binds the Nerve Agent Cyclosarin and Spontaneously Hydrolyzes the Nerve Agent Sarin , 2010, Molecular Pharmacology.

[7]  B. Cravatt,et al.  Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study* , 2010, The Journal of Biological Chemistry.

[8]  L. Sultatos,et al.  An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon. , 2009, Toxicology and Applied Pharmacology.

[9]  Yu-Jui Yvonne Wan,et al.  Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. , 2009, Biochemical pharmacology.

[10]  S. Gwaltney,et al.  Evaluation of the ‘side door’ in carboxylesterase-mediated catalysis and inhibition , 2008, Biological chemistry.

[11]  Charles Timchalk,et al.  An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  J. Laitinen,et al.  Monoglyceride Lipase as an Enzyme Hydrolyzing 2‐Arachidonoylglycerol , 2007, Chemistry & biodiversity.

[13]  D. Barr,et al.  Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. , 2007, American journal of epidemiology.

[14]  N. Jewell,et al.  Organophosphate Pesticide Exposure and Neurodevelopment in Young Mexican-American Children , 2007, Environmental Health Perspectives.

[15]  Tetsuo Satoh,et al.  Structure, function and regulation of carboxylesterases. , 2006, Chemico-biological interactions.

[16]  P. Potter,et al.  Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. , 2006, Biochemical pharmacology.

[17]  R. Jackson,et al.  Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. , 2003, Environmental health perspectives.

[18]  C Timchalk,et al.  A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  C. Pope,et al.  Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  C. Morton,et al.  Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression , 2000, Molecular biotechnology.

[21]  C. Morton,et al.  Proficient metabolism of irinotecan by a human intestinal carboxylesterase. , 2000, Cancer research.

[22]  V. Moser,et al.  Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  B. P. Doctor,et al.  Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. , 1998, Biochemical pharmacology.

[24]  J. Chambers,et al.  Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. , 1997, Toxicology and applied pharmacology.

[25]  T. Langmann,et al.  Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. , 1997, Biochemical and biophysical research communications.

[26]  W. Norman Aldridge,et al.  Mechanisms and Concepts in Toxicology , 1996 .

[27]  H. Beaufay,et al.  The COOH terminus of several liver carboxylesterases targets these enzymes to the lumen of the endoplasmic reticulum. , 1991, The Journal of biological chemistry.

[28]  J. Chambers,et al.  Noncatalytic detoxication of six organophosphorus compounds by rat liver homogenates. , 1990 .

[29]  S. D. Murphy,et al.  The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats. , 1975, Toxicology and applied pharmacology.

[30]  A. Main.  Affinity and Phosphorylation Constants for the Inhibition of Esterases by Organophosphates , 1964, Science.

[31]  W. Dauterman,et al.  Determination of the Bimolecular Rate Constant for the Reaction Between Organophosphorous Inhibitors and Esterases in the Presence of Substrate , 1963, Nature.

[32]  Shobha Ghosh,et al.  Macrophage cholesteryl ester mobilization and atherosclerosis. , 2010, Vascular pharmacology.

[33]  P. Potter,et al.  Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. , 2010, Biochimica et biophysica acta.

[34]  J. Casida,et al.  Sensitivity of blood‐clotting factors and digestive enzymes to inhibition by organophosphorus pesticides , 2000, Journal of biochemical and molecular toxicology.

[35]  L G Sultatos,et al.  Common mechanism of toxicity: a case study of organophosphorus pesticides. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  S. Brimijoin,et al.  Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? , 1998, Toxicology and applied pharmacology.

[37]  Children.  Pesticides in the Diets of Infants and Children , 1993 .

[38]  D. M. Maxwell.  9 – Detoxication of Organophosphorus Compounds by Carboxylesterase , 1992 .

[39]  C. Pope,et al.  Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. , 1991, Toxicology.

[40]  W. Aldridge.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. , 1953, The Biochemical journal.